gemcitabine has been researched along with Pseudomyxoma Peritonei in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akazawa, Y; Isomoto, H; Kohno, S; Mizuta, Y; Nakagoe, T; Ohara, H; Ohba, K; Ohnita, K; Omagari, K; Shiozawa, K; Shirono, K; Takeshima, F; Tanaka, K; Yasutake, T | 1 |
Eisele, L; Müller-Beissenhirtz, H; Seeber, S; Sheu, SY; Welt, A | 1 |
1 review(s) available for gemcitabine and Pseudomyxoma Peritonei
Article | Year |
---|---|
Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Pancreatic Ductal; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Peritoneal Neoplasms; Pseudomyxoma Peritonei | 2005 |
1 other study(ies) available for gemcitabine and Pseudomyxoma Peritonei
Article | Year |
---|---|
Response of pseudomyxoma peritonei to gemcitabine.
Topics: Aged; Antineoplastic Agents; Cystadenocarcinoma, Mucinous; Deoxycytidine; Gemcitabine; Humans; Male; Peritoneal Neoplasms; Pseudomyxoma Peritonei | 2006 |